In vitro activity of tigecycline and comparators against Gram-positive and Gram-negative isolates collected from the Middle East and Africa between 2004 and 2011

International Journal of Antimicrobial Agents

Volumn 43, Issue 2, 2014, Pages 170-178

  Kanj, Souha S ^a   Whitelaw, Andrew ^b,c   Dowzicky, Michael J ^d  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

^d PFIZER INC   (United States)

Author keywords

Africa; Antimicrobial susceptibility; Gram negative; Gram positive; Middle East; Tigecycline

Indexed keywords

AFRICA; ANTIMICROBIAL SUSCEPTIBILITY; GRAM-NEGATIVE; GRAM-POSITIVE; MIDDLE EAST; TIGECYCLINE;

AFRICA; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIA; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MIDDLE EAST; MINOCYCLINE;

EID: 84893712171     PISSN: 09248579     EISSN: 18727913     Source Type: Journal    
DOI: 10.1016/j.ijantimicag.2013.10.011     Document Type: Article

References (15)

1. OXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital Antimicrob Agents Chemother 52 2008 4115 4120
2. A.J. Brink, R.F. Botha, X. Poswa, M. Senekal, R.E. Badal, and D.C. Grolman et al. Antimicrobial susceptibility of Gram-negative pathogens isolated from patients with complicated intra-abdominal infections in South African hospitals (SMART Study 2004-2009): impact of the new carbapenem breakpoints Surg Infect (Larchmt) 13 2012 43 49
3. ® product insert 2011 Pfizer Inc. Philadelphia, PA http://www.pfizerpro.com/hcp/tygacil [accessed 06.11.13]
4. X. Bertrand, and M.J. Dowzicky Antimicrobial susceptibility among Gram-negative isolates collected from intensive care units in North America, Europe, the Asia-Pacific Rim, Latin America, the Middle East, and Africa between 2004 and 2009 as part of the Tigecycline Evaluation and Surveillance Trial Clin Ther 34 2012 124 137
5. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. Document M7-A8 8th ed. 2009 CLSI Wayne, PA
6. A. Balode, V. Punda-Polić, and M.J. Dowzicky Antimicrobial susceptibility of Gram-negative and Gram-positive bacteria collected from countries in Eastern Europe: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) 2004-2010 Int J Antimicrob Agents 41 2013 527 535
7. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Document M100-S23 2013 CLSI Wayne, PA
8. G.F. Araj, A.Z. Avedissian, N.S. Ayyash, H.A. Bey, R.G. El Asmar, and R.Z. Hammoud et al. A reflection on bacterial resistance to antimicrobial agents at a major tertiary care center in Lebanon over a decade J Med Liban 60 2012 125 135
9. Y. Taj, F.E. Abdullah, and S.U. Kazmi Current pattern of antibiotic resistance in Staphylococcus aureus clinical isolates and the emergence of vancomycin resistance J Coll Physicians Surg Pak 20 2010 728 732
10. M.M. Salem-Bekhit, I.M. Moussa, M.M. Muharram, F.K. Alanazy, and H.M. Hefni Prevalence and antimicrobial resistance pattern of multidrug-resistant enterococci isolated from clinical specimens Indian J Med Microbiol 30 2012 44 51
11. J.A. Shin, Y.S. Chang, H.J. Kim, S.K. Kim, J. Chang, and C.M. Ahn et al. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection Yonsei Med J 53 2012 974 984
12. G.F. Araj, and G.Y. Ibrahim Tigecycline in vitro activity against commonly encountered multidrug-resistant Gram-negative pathogens in a Middle Eastern country Diagn Microbiol Infect Dis 62 2008 411 415
13. M. Al-Yaqoubi, and K. Elhag Susceptibilities of common bacterial isolates from Oman to old and new antibiotics Oman Med J 23 2008 173 178
14. H.S. Sader, R.K. Flamm, and R.N. Jones Tigecycline activity tested against antimicrobial resistant surveillance subsets of clinical bacteria collected worldwide (2011) Diagn Microbiol Infect Dis 76 2013 217 221
15. M. Linkevicius, L. Sandegren, and D.I. Andersson Mechanisms and fitness costs of tigecycline resistance in Escherichia coli Antimicrob Chemother 2013 [Epub ahead of print]